Delivery Order SPE2DB22D2206-SPE2DB24FFD65
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $33K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $18,985.48 for the supply of Pulmozyme 1 mg/ml ampuls. The contract is with the Defense Logistics Agency Troop Support Medical and has an ultimate completion date of May 22, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a...
- This federal contract award, valued at $68,193.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml). The contract has a firm fixed price and an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order under its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,881.52, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL. The $2,410.99 firm fixed-price contract has a completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA for a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,601.82 delivery order contract is for the supply of Pulmozyme 1 mg/mL ampuls, a medication used to treat cystic fibrosis. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 29, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a specialty medication. The $5,231 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product Pulmozyme 1 mg/ml ampul 2.5ml to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $8,462.13, has an ultimate completion date of April 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.99, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Pulmozyme (dornase alfa) medication in 2.5 ml ampules. The contract has a ceiling value of $2,546.49 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is May 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. government has awarded a Delivery Order contract (SPE2DX15D1022|SPE2DX24FVDJJ) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply the pharmaceutical product Pulmozyme 1 mg/ml Ampul 2.5 ml. The contract has a ceiling value of $20,979.35 and has an ultimate completion date of February 8, 2024. The contract is a Firm Fixed Price award, and there was no set-aside designation used. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a...